No­vo Nordisk inks re­search deal with RNA start­up with new de­liv­ery ap­proach

No­vo Nordisk is col­lab­o­rat­ing with RNA up­start Eleven Ther­a­peu­tics in a bid to iden­ti­fy new med­i­cines that can de­liv­er nu­cle­ic acids.

The deal, an­nounced Mon­day morn­ing, will uti­lize Eleven’s plat­form, dubbed “DE­Liv­eri,” to iden­ti­fy po­ten­tial mol­e­cules that can de­liv­er nu­cle­ic acid ther­a­peu­tics to treat undis­closed car­diometa­bol­ic dis­eases. It gives No­vo ex­clu­sive ac­cess to cer­tain cell types and ap­pli­ca­tions that are as­so­ci­at­ed with the plat­form, ac­cord­ing to a press re­lease. Fi­nan­cial de­tails were not dis­closed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER